Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]
<p>Abstract</p> <p>Background</p> <p>Amyotrophic lateral sclerosis is a rapidly progressive neurodegenerative disorder characterised by loss of motor neurons leading to severe weakness and death from respiratory failure within 3-5 years. Riluzole prolongs survival in AL...
Main Authors: | Kelly Joanna, Thornhill Marie, Murphy Caroline, Morrison Karen E, Young Carolyn A, Shaw Pamela J, Al-Chalabi Ammar, Steen I Nicholas, Leigh P Nigel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | BMC Neurology |
Online Access: | http://www.biomedcentral.com/1471-2377/11/111 |
Similar Items
-
Amyotrophic lateral sclerosis
by: Leigh P Nigel, et al.
Published: (2009-02-01) -
What causes amyotrophic lateral sclerosis? [version 1; referees: 3 approved]
by: Sarah Martin, et al.
Published: (2017-03-01) -
The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci.
by: Louise V Wain, et al.
Published: (2009-12-01) -
Dosimetry of <sup>177</sup>Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol
by: Anna Sarnelli, et al.
Published: (2019-02-01) -
Metamoraphic history of granulite grade lithologies and associated igneous rocks viz., carbonatites and syenites around periyakulam and varushanadu licalities: Implications for the evolution of 550 ma old southern granulite terrain
by: Basava, Sharana
Published: (2007)